D. E. Shaw & Co., Inc. Opiant Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$10.12 - $23.32 $70,283 - $161,957	-6,945 Reduced 40.88%	10,044 $120,000
Q1 2022 May 16, 2022	BUY	$19.54 - $33.59 $331,965 - $570,660	16,989 New	16,989 $364,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.